Vox Sanguinis

Papers
(The TQCC of Vox Sanguinis is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Issue Information27
25
Issue Information22
Evaluation of bleed duration and adverse donor reactions during the blood donation process21
Anti‐D prophylaxis should protect all newborns from haemolytic disease, regardless of their country of residence21
Issue Information20
Therapeutic granulocyte infusion for patients with severe neutropaenia and neutrophilic dysfunction: New Zealand experience19
Human neutrophil antigen 2 sequence‐based typing: Joining the hunt for the CD177 answer16
Reported non‐compliance with pre‐donation screening among blood donors in Québec, Canada: A focus on the 3‐month deferral for men who have sex with men13
Basophil activation test for allergic and febrile non‐haemolytic transfusion reactions among paediatric patients with haematological or oncological disease13
A positive blood culture is associated with a lower haemoglobin increment in hospitalized patients after red blood cell transfusion13
Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal RNA screening in France12
Quality assessment and harmonization of laboratories across Europe for multiple SARS‐CoV‐2 serology assays12
Removing hepatitis C antibody testing for Australian blood donations: A cost‐effectiveness analysis12
Transfusion‐associated acute lung injury following albumin treatment in liver disease12
Issue Information11
Cord blood freezing bag breakage at transplant centres: Low breakage rate in Japan11
The prototypical UK blood donor, homophily and blood donation: Blood donors are like you, not me11
A novel syphilis Treponema pallidum lipoprotein peptide antigen diagnostic assay using red cell kodecytes in routine blood centre column agglutination testing platforms11
Anti‐monkeypox virus‐neutralizing activities of human immunoglobulin manufactured between 1999 and 2021 and derived from donors in the United States and Japan11
Issue Information11
West Nile and Usutu viruses are efficiently inactivated in platelet concentrates by UVC light using the THERAFLEX UV‐Platelets system11
Has the switch to sexual risk behaviour screening impacted deferrals for pre‐ and post‐exposure prophylaxis therapy for human immunodeficiency virus?10
10
Events10
Voluntary blood donation preferences in China: A discrete choice experiment among experienced and inexperienced donors10
Issue Information10
10
Virtual platelet cross‐matching as transfusion management for patients with immune platelet refractoriness9
Evaluation of immunoglobulin replacement therapy in secondary immunodeficiency at three British Columbia hospitals9
Corrigendum9
Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries9
Events9
Development of an in‐house bone marrow collection kit: The Catalan bone marrow transplantation group experience9
Notification of blood donors who test positive for transfusion‐transmissible infections9
Non‐neutralizing antibody profiles against hepatitis B virus: A comparative study of Japanese‐ and US‐donor‐derived intramuscular human hepatitis B‐specific immunoglobulin preparations8
Research partnerships between blood services and public health authorities: An international, cross‐sectional survey8
Real‐world performance of a clinical droplet digital polymerase chain reaction assay for non‐invasive foetal blood group and platelet antigen genotyping of alloimmunized pregnant women with antibodies8
The association of B blood group with SARS‐CoV‐2‐induced death in Babol, north of Iran8
Low‐dose prophylaxis and its impact on the health of haemophilia patients8
Re‐evaluating treatment thresholds in patient blood management: Female patients experience more perioperative anaemia and higher transfusion rates in major elective surgery8
Blood transfusion dynamics in Colombia: Unveiling patterns, reactions and survival rates in multitransfused patients8
HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men8
Impact of restrictive red blood cell transfusion strategy on thrombosis‐related events: A meta‐analysis and systematic review8
Ludwik Hirszfeld: A pioneer of transfusion and immunology during the world wars and beyond8
RhD mismatch does not affect haematopoietic recovery, graft‐versus‐host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry‐based study8
Deferral of blood donors who have ever stayed in a Trypanosoma cruzi endemic area: An international survey8
The role of CD36 antibodies in haematopoietic stem cell transplantation7
Securing commitment and control for the supply of plasma derivatives for public health systems. I: A short review of the global landscape7
Characterization of transfusion‐relevant bacteria reference strains in a lyophilized format7
Effects of dual chelation therapy with deferasirox and deferoxamine in patients with beta thalassaemia major7
Identification of a novel variant c.761C>T onABO*B.01gene in ABO glycosyltransferases associated with Bweakphenotype7
Plasma transfusion practices: A multicentre electronic audit7
International Forum on Transfusion Education for Healthcare Professionals Who Administer Blood to Patients in Hospitals and Health Services: Summary7
Evidence that CD36 is expressed on red blood cells and constitutes a novel blood group system of clinical importance7
Plasma procurement and plasma product safety in light of the COVID‐19 pandemic from the perspective of the plasma industry7
Successful implementation of a patient blood management programme in a lower middle‐income state7
7
End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral7
ABO haemolytic disease of the newborn: Improved prediction by novel integration of causative and protective factors in newborn and mother7
Proof of concept for detection of staphylococcal enterotoxins in platelet concentrates as a novel safety mitigation strategy7
Ethnic diversity in Chilean blood groups: A comprehensive analysis of genotypes, phenotypes, alleles and the immunogenic potential of antigens in northern, southern and central regions6
Breast milk contains red cell isohaemagglutinins: An observational study of 176 mothers6
A norm for all seasons: Application of the ISO 14001 standard to manage the environmental impacts of transfusion6
Evaluation of a method to fluorescently label platelets for in‐human recovery and survival studies6
Author Index6
International Forum on Genotyping of Blood Antigens in Donors: Summary6
Laboratory approach for vaccine‐induced thrombotic thrombocytopenia diagnosis in the Netherlands6
Standardized electronic messages to enhance communication in transfusion and transplantation6
Is it time for the death knell of single‐unit plasma?6
Prediction and impact of personalized donation intervals6
Issue Information6
Events6
Molecular biology analysis of ABO blood group variants caused by natural chimaerism6
Analysis of maternal Fc gamma receptor IIIb isoantibodies using immunomagnetic negative selected neutrophils6
Use of O RhD‐negative red blood cells: A nationwide, prospective audit6
Issue Information6
Screening, genotyping and haematological analysis of glucose‐6‐phosphate dehydrogenase deficiency in the blood donors of Wuxi City, China5
The availability of plasma donors and plasma: A sociologist's perspective5
Diary of Events5
Risk of variant CreutzfeldtJakob disease in a simulated cohort of Canadian blood donors5
Preventing alloimmunization using a new model for matching extensively typed red blood cells5
5
Current state of gene therapy in sickle cell disease5
5
Coagulation assay results at birth in preterm infants: A cohort study highlighting the relevance of local reference values for interpretation5
Evaluation of cell collection efficiency in non‐mobilized adult donors for autologous chimeric antigen receptor T‐cell manufacturing5
Events5
Frequency of human platelet antigens (HPA) in the Greek population as deduced from the first registry of HPA‐typed blood donors5
In vitro comparison of cold‐stored whole blood and reconstituted whole blood5
Age, CD34+ cell dose, conditioning and pre‐transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation5
The impact of non‐disclosure of HIV status and antiretroviral therapy on HIV recency testing and incidence algorithms5
Hepatitis B virus genotype surveillance in Canadian blood donors and a referred patient population, 2016–20215
Tetanus antibodies in normal human immunoglobulin preparations5
Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID‐19 convalescent plasma5
Alemtuzumab and autoimmune haemolytic anaemia: Coincidence or causation?5
Meta‐analysis of efficacy and safety of pathogen‐reduced platelet components: Request for clarification5
5
Assessment of amino acids and metabolites in the supernatant of stored concentrates blood from sickle cell trait (SCT) and reference (non‐SCT) donors5
Can volume‐reduced plasma products prevent transfusion‐associated circulatory overload in a two‐hit animal model?5
Issue Information5
The contemporary management of haemolytic disease of the fetus and newborn5
The association between attitude towards facemasks, quality of donation experience and relationship with healthcare providers: A cross‐sectional exploratory study5
Development and validation of a scoring system to predict vasovagal reaction upon whole‐blood donation5
5
Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance5
Advancing resilience and sustainability in plasma collections and plasma‐derived medicinal product accessibility5
5
Closed system production of serum eye drops using dockable saline5
Issue Information5
Issue Information5
Events5
Events5
Sequence variants in the proximal promoter and +5.8‐kb site of ABO in Koreans with weak B phenotypes5
5
Characteristics of red blood cell transfusion among very preterm infants in China5
Diary of Events4
Autoantibodies to ADAMTS13 in human immunodeficiency virus‐associated thrombotic thrombocytopenic purpura4
4
The continued decline of plasma transfusions in Taiwan: An 11‐year population‐based study4
Issue Information4
Transfusion efficacy of leucoreduced packed red blood cells prepared by two different methods: A randomized controlled trial in transfusion‐dependent thalassaemia patients (FUEL trial)4
Diary of Events4
Prediction of blood volume to be processed to achieve a target number of CD34+ cells: Development, validation and implementation of a formula4
Use of preoperative erythropoietin‐stimulating agents is associated with decreased thrombotic adverse events compared to red blood cell transfusion in surgical patients with anaemia4
RHDalleles contributing to serologically weak D phenotypes in China: A single‐centre study over 10 years4
4
The selection and preparation of red cell components for intrauterine transfusion: A national survey4
Split red blood cell units contain defined extracellular K+ levels, which are improved by a washing procedure4
Events4
The safety of pathogen‐reduced platelet transfusions in critically ill term and preterm neonates4
Analysis of wrong blood in tube events at a hospital‐based blood centre in a tertiary care referral hospital: A perspective from a lower middle‐income country4
Incentives for plasma donation4
Issue Information4
International Society for Blood Transfusion Guidelines for Validation of Automated Systems in Blood Establishments4
Analysis of gender representation on transfusion medicine journal editorial boards: Comparison between 2019 and 20224
Does high body mass index (>25 kg/m2) or weight (>80 kg) reduce the effectiveness of anti‐D prophylaxis in Rh(D)‐negative pregnant women? A systematic review and meta‐analysis4
Associated criteria used in investigating suspected septic transfusion reactions: A scoping review4
The evolution and interpretation of seroprevalence of SARS‐CoV‐2 antibodies among South African blood donors from the Beta to Omicron variant‐driven waves4
Determination of CD177 (human neutrophil antigen 2) polymorphisms using nanopore sequencing4
Diary of Events4
Issue Information4
Impact of donor ferritin testing on iron deficiency prevention and blood availability in France: A cohort simulation study4
Transfusion‐related acute lung injury induced by human leucocyte antigen‐II antibodies: Analysis of antibody typing and source4
Donors in the COVID‐19 era: How did donor characteristics change in Japan?4
Issue Information4
Author Index4
Time–temperature indicators versus temperature indicators for transfusion practice: Application in the real hospital setting4
The effect of near‐infrared low‐level light on the in vitro quality of platelets during storage4
Dual preparation of plasma and platelet concentrates in platelet additive solution from platelet concentrates in plasma using a novel filtration system4
Blood collection technique and processing impact the nucleosomes and complement contents of platelet products4
International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and three virtual business meetings: Update on blood group systems3
For whole blood research, look to the whole world3
Prevalence of adsorbed A antigen onto donor‐derived group O red cells in children following stem cell transplantation: A single‐centre evaluation3
A comparison between liquid group A plasma and thawed group A plasma for massive transfusion activation in trauma patients3
Extending the post‐thaw shelf‐life of cryoprecipitate when stored at refrigerated temperatures3
Therapeutic efficacy and safety of pathogen‐reduced platelet components: Results of a meta‐analysis of randomized controlled trials3
The impact of COVID‐19 outbreak on the Transfusion Medicine Unit of a Northern Italy Hospital and Cancer Centre3
Cold storage alters the immune characteristics of platelets and potentiates bacterial‐induced aggregation3
Effects of plasmapheresis frequency on health status and exercise performance in men: A randomized controlled trial3
Molecular blood group screening in Omani blood donors3
HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta‐analysis)3
Using competition for plasma donor recruitment and retention: An Australian university case study3
Impact of the pathogen inactivation process on the migration of di(2‐ethylhexyl) phthalate from plasma bags3
Facilitators of and barriers to blood donation among voluntary non‐remunerated blood donors in sub‐Saharan Africa: A scoping review3
Expansion strategies for umbilical cord blood haematopoietic stem cells in vitro3
Management of blood transfusion services in low‐resource countries3
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID‐19 pandemic3
Platelets retain function and can be stored following disruption of human leucocyte antigens3
Issue Information3
A retrospective analysis of postpartum red blood cell transfusions at a tertiary care obstetric centre3
3
The importance of confirmatory assays in testing blood donors for human T‐cell lymphotropic virus3
Monitoring viral genomic sequences in transfusion‐transmitted viruses3
Eye drops of human origin—Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies3
Use of plerixafor to mobilize haematopoietic progenitor cells in healthy donors3
Simulated effects of ferritin screening on C‐reactive protein levels in recruited blood donors3
International Forum on Gender Identification and Blood Collection: Responses3
Comparative evaluation of efficacy and safety of automated versus manual red cell exchange in sickle cell disease: A systematic review and meta‐analysis3
Safeguarding plasma for fractionation: How can we deal with operational challenges in European Union countries3
Motivation, blood donor satisfaction and intention to return during the COVID‐19 pandemic3
3
A comprehensive approach to continuous quality improvement of massive transfusion by developing key performance indicators3
Estimation of Lewis‐negative alleles by high‐resolution melting analysis of three tag SNPs of FUT33
The impact of donor ferritin testing on blood availability in Canada3
Detecting serologically difficult ABO blood groups using single‐molecule real‐time sequencing technology3
Issue Information3
Influence of donor age, sex and ethnicity on high‐titre anti‐A and ‐B: Review of 6 million donations from two national blood providers3
Reply to Watchko and Maisels: Exchange transfusion in Rh haemolytic disease3
Blood transfusion is associated with increased mortality for neonates with congenital diaphragmatic hernia on extracorporeal membrane oxygenation support3
Validation of a flow‐cytometry‐based red blood cell antigen phenotyping method3
A pilot randomized clinical trial of cryopreserved versus liquid‐stored platelet transfusion for bleeding in cardiac surgery: The cryopreserved versus liquid plateletNew Zealand pilot tria3
International Forum on Management of Blood Donors with Culture‐Positive Platelet Donations: Responses3
ABO blood type analysis of the donors of convalescent plasma after COVID‐19 infection in Chelyabinsk region, Russia3
Rapid genotyping of 508G>A (rs3745635) and 1067T>A (rs3894326) of FUT3 by a duplex Eprobe‐mediated melting curve analysis3
3
Comparison of automated versus semi‐automated whole blood processing systems: A systematic review3
Paediatric clinical decision support: Evaluation of a best practice alert for red blood cell transfusion3
0.12922310829163